Why Green Organic Dutchman’s (TGOD) Stock Price Rose 14% in August

Green Organic Dutchman Holdings (TSX:TGOD) is one of the most promising pot stocks on the market, but its valuation has often struggled due to its small size. Valued at only $750 million, Green Organic only gets a fraction of the attention that bigger cannabis companies get. Canopy Growth and Cronos Group, for example, are both worth several billions. The value disconnect…

Read More

Why Cronos (TSX:CRON) Stock Fell 14% in August

Cronos Group (TSX:CRON)(NASDAQ:CRON) was one of the best-performing pot stocks in history. In 2016, shares were worth just $0.20 apiece. This March, shares surpassed the $29 mark. A $10,000 investment would have been worth nearly $1.5 million. Over the last six months, however, shares have struggled, falling as much as 50%. Last month, the declines continued, with the stock losing 14%…

Read More

Is Cronos (TSX:CRON) Headed Further Down in Price?

Things could be about to get even worse for Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). Since March, the stock has been plummeting, losing around half of its value during that time. The stock has been heavily overpriced for some time now — with plenty of room to continue falling, especially now that one analyst has adjusted their target for the stock. Last week,…

Read More

Better CBD Stock: Charlotte’s Web (TSX:CWEB) vs. Cronos (TSX:CRON)

While Canadians might be gearing up for the introduction of the edibles market, across the border, cannabidiols (CBD) have been the hottest trend as of late. CBD provides a lot of the medicinal benefits of marijuana without the actual high. CBD oil comes from the hemp plant, which is actually a cousin of the marijuana plant and not actually marijuana.…

Read More

Why Did Hexo (TSX:HEXO) Fall 4.1% in August?

Shares of Hexo (TSX:HEXO)(NYSE:HEXO) fell 4.1% last month. Despite the loss in market value, Hexo managed to outperform the cannabis index and peers. Horizons Marijuana Life Sciences ETF fell 13% last month, while major players such as Aurora Cannabis, Canopy Growth, and Cronos fell 11%, 27%, and 19%, respectively, in August 2019. Hexo accounts for 3.9% of HMMJ. Canopy Growth,…

Read More

Should You Buy Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) or Individual Pot Stocks?

Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) is the world’s first marijuana ETF. It seeks to replicate the performance of the North American Marijuana Index, net of expenses. This index gives exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. Issuers have in general a market…

Read More

Why Did Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) Fall 13% in August?

Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) fell over 13% in August 2019. This ETF has returned -25% in the last three months and -19% in the last six months. HMMJ’s top holdings include Aurora Cannabis (TSX:ACB)(NYSE:ACB), Canopy Growth (TSX:WEED)(NYSE:CGC), and Cronos Group (TSX:CRON)(NASDAQ:CRON). Aurora Cannabis accounts for 10.3% of HMMJ, followed by Canopy Growth at 9.4% and Cronos at…

Read More

Why Cronos Group (TSX:CRON) Is Still Too Expensive, Even at $14/Share

The deepening cannabis rout has brought down valuations across the sector, and even lavish names like Cronos Group (TSX:CRON)(NASDAQ:CRON) are beginning to look a lot more attractive, now that they’re trading at half of where they used to be. However, Cronos’s market cap only tells part of the story: even at these levels, Cronos remains a richly valued stock, whose…

Read More

3 High-Growth Stocks Poised to Soar in the Next Year

The strong cannabis stocks are beginning to distinguish themselves from the weaker, less-competitive companies. Through robust sales growth post-cannabis legalization, Aphria (TSX:APHA)(NYSE:APHA), Supreme Cannabis Company (TSX:FIRE), and Cronos (TSX:CRON)(NASDAQ:CRON) have all shown investors what they are worth. During the bear market sell-off this past month resulting from U.S. president Donald Trump’s trade war, these three pot stocks performed very well…

Read More

Forget Canopy Growth (TSX:WEED): Buy These 3 Pot Stocks Instead

If you’ve been invested in Canopy Growth for a while now — as I have — then I’m certainly not going to start off by saying you should sell off all your stake. The company has been through a whirlwind lately that has left investors unsure of the company’s immediate future. However, if you’re aiming to buy and hold this stock for…

Read More